Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This study is a randomized, double-blind (Investigator and study subject), placebo controlled multiple dose sequential ascending dose study that will enroll up to 47 male and female subjects with type 2 diabetes mellitus (T2DM) in up to four cohorts.
Epistemonikos ID: 00884cc9d0598548a3be9b61e689e0be6ffa1f1f
First added on: May 12, 2024